(MedPage Today) -- A drug giant is betting big on beta-amyloid as a therapeutic target in symptomatic Alzheimer's disease. Also this week: a comprehensive report card on global health. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment